These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30406708)

  • 1. No preventive or therapeutic efficacy of infliximab against macrophage activation syndrome due to systemic juvenile idiopathic arthritis.
    Kiuchi Z; Ogura M; Sato M; Kamei K; Ishikura K; Abe J; Ito S
    Scand J Rheumatol; 2019 May; 48(3):246-248. PubMed ID: 30406708
    [No Abstract]   [Full Text] [Related]  

  • 2. Sudden Hypotension and Increased Serum Interferon-γ and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis.
    Guo L; Xu Y; Qian X; Zou L; Zheng R; Teng L; Zheng Q; Leung Jung LK; Lu M
    J Pediatr; 2021 Aug; 235():203-211.e3. PubMed ID: 33581106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient natural killer cell dysfunction associated with interleukin-18 overproduction in systemic juvenile idiopathic arthritis.
    Takakura M; Shimizu M; Yakoyama T; Mizuta M; Yachie A
    Pediatr Int; 2018 Oct; 60(10):984-985. PubMed ID: 30345698
    [No Abstract]   [Full Text] [Related]  

  • 4. Outcome of PatientsWith Systemic Onset Juvenile Idiopathic Arthritis With Macrophage Activation Syndrome at Onset.
    Raghuram J; Gornale VK; Rao AP
    Indian Pediatr; 2021 Jan; 58(1):87. PubMed ID: 33452788
    [No Abstract]   [Full Text] [Related]  

  • 5. Adenosine deaminase 2 as a biomarker of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
    Lee PY; Schulert GS; Canna SW; Huang Y; Sundel J; Li Y; Hoyt KJ; Blaustein RB; Wactor A; Do T; Halyabar O; Chang MH; Dedeoglu F; Case SM; Meidan E; Lo MS; Sundel RP; Richardson ET; Newburger JW; Hershfield MS; Son MB; Henderson LA; Nigrovic PA
    Ann Rheum Dis; 2020 Feb; 79(2):225-231. PubMed ID: 31707357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Bracaglia C; de Graaf K; Pires Marafon D; Guilhot F; Ferlin W; Prencipe G; Caiello I; Davì S; Schulert G; Ravelli A; Grom AA; de Min C; De Benedetti F
    Ann Rheum Dis; 2017 Jan; 76(1):166-172. PubMed ID: 27296321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
    Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome.
    Wagner-Weiner L
    Pediatr Ann; 2015 Jun; 44(6):e142-7. PubMed ID: 26114369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of macrophage activation syndrome due to systemic onset juvenile idiopathic arthritis with antithymocyte globulin.
    Ozturk K; Ekinci Z
    Rheumatol Int; 2015 Oct; 35(10):1779-80. PubMed ID: 26210998
    [No Abstract]   [Full Text] [Related]  

  • 10. Paediatric rheumatic disease: Diagnosing macrophage activation syndrome in systemic JIA.
    Vastert SJ; Prakken BJ
    Nat Rev Rheumatol; 2014 Nov; 10(11):640-2. PubMed ID: 25201384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
    Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
    Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary varicella infection in children with systemic juvenile idiopathic arthritis under tocilizumab therapy.
    Nozawa T; Nishimura K; Ohara A; Hara R; Ito S
    Mod Rheumatol; 2019 May; 29(3):558-562. PubMed ID: 27846755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRECORDIAL PAIN, LEUKOCYTOSIS AND BICYTOPENIA IN A TEENAGER WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS UNDER IMMUNOSUPPRESSIVE THERAPY.
    Vieira MS; Andrade FR; Brandão LMKR; Nóbrega VTD; Guissa VR; Provenza JR
    Rev Paul Pediatr; 2019; 37(2):252-256. PubMed ID: 30810692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation syndrome: Experience in the questioned role of etoposide.
    Conde LF; Aedo KP; Miraval-Niño de Guzmán T
    Reumatol Clin; 2017; 13(4):239-240. PubMed ID: 28041909
    [No Abstract]   [Full Text] [Related]  

  • 15. Macrophage Activation Syndrome secondary to Systemic Juvenile Idiopathic Arthritis: A Case Report.
    Kafle R; Bhatta A; Gami S; Sapkota A; Sharma D; Yadav A; Chikanbanjar VK
    JNMA J Nepal Med Assoc; 2021 Nov; 59(243):1166-1169. PubMed ID: 35199753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 50 Years Ago in TheJournalofPediatrics: Hepatic Dysfunction in Systemic Juvenile Idiopathic Arthritis with Alleviation of Arthritis: The First Description of Macrophage Activation Syndrome?
    Ashkenazi L; Hashkes PJ
    J Pediatr; 2021 Jul; 234():64. PubMed ID: 34172168
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of serum cytokine profiles in macrophage activation syndrome complicating different background rheumatic diseases in children.
    Mizuta M; Shimizu M; Irabu H; Usami M; Inoue N; Nakagishi Y; Wada T; Yachie A
    Rheumatology (Oxford); 2021 Jan; 60(1):231-238. PubMed ID: 32681176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leucine-rich α2-glycoprotein as the acute-phase reactant to detect systemic juvenile idiopathic arthritis disease activity during anti-interleukin-6 blockade therapy: A case series.
    Shimizu M; Nakagishi Y; Inoue N; Mizuta M; Yachie A
    Mod Rheumatol; 2017 Sep; 27(5):833-837. PubMed ID: 28094589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation syndrome in an inadequately treated patient with systemic onset juvenile idiopathic arthritis.
    Juneja M; Jain R; Mishra D
    Kathmandu Univ Med J (KUMJ); 2009; 7(28):411-3. PubMed ID: 20502084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
    Schulert GS; Minoia F; Bohnsack J; Cron RQ; Hashad S; KonÉ-Paut I; Kostik M; Lovell D; Maritsi D; Nigrovic PA; Pal P; Ravelli A; Shimizu M; Stanevicha V; Vastert S; Woerner A; de Benedetti F; Grom AA
    Arthritis Care Res (Hoboken); 2018 Mar; 70(3):409-419. PubMed ID: 28499329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.